Mauro Malnati
Overview
Explore the profile of Mauro Malnati including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
488
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Noviello M, De Lorenzo R, Chimienti R, Maugeri N, De Lalla C, Siracusano G, et al.
Front Immunol
. 2024 Aug;
15:1381091.
PMID: 39136010
Introduction: SARS-CoV-2 pandemic still poses a significant burden on global health and economy, especially for symptoms persisting beyond the acute disease. COVID-19 manifests with various degrees of severity and the...
2.
Chimienti R, Baccega T, Torchio S, Manenti F, Pellegrini S, Cospito A, et al.
Cell Rep
. 2022 Sep;
40(13):111423.
PMID: 36170817
Induced pluripotent stem cells (iPSCs) represent a source from which β cells can be derived for diabetes replacement therapy. However, their application may be hindered by immune-mediated responses. Although abrogation...
3.
Biswas P, Dellanoce C, Vezzoli A, Mrakic-Sposta S, Malnati M, Beretta A, et al.
Nutrients
. 2020 Oct;
12(11).
PMID: 33105552
The effects of two different dietary supplements on the redox status of healthy human participants were evaluated. The first supplement (GluS, Glutathione Synthesis) contains the precursors for the endogenous synthesis...
4.
Gazzerro E, Baratto S, Assereto S, Baldassari S, Panicucci C, Raffaghello L, et al.
Am J Pathol
. 2018 Nov;
189(2):354-369.
PMID: 30448410
In muscular dystrophies, muscle membrane fragility results in a tissue-specific increase of danger-associated molecular pattern molecules (DAMPs) and infiltration of inflammatory cells. The DAMP extracellular ATP (eATP) released by dying...
5.
Parolini F, Biswas P, Serena M, Sironi F, Muraro V, Guizzardi E, et al.
J Virol
. 2018 Aug;
92(17).
PMID: 30115775
No abstract available.
6.
Serena M, Parolini F, Biswas P, Sironi F, Miranda A, Zoratti E, et al.
Sci Rep
. 2018 May;
8:46991.
PMID: 29786690
This corrects the article DOI: 10.1038/srep40037.
7.
Parolini F, Biswas P, Serena M, Sironi F, Muraro V, Guizzardi E, et al.
J Virol
. 2017 Oct;
92(1).
PMID: 29070683
HLA-C expression is associated with a differential ability to control HIV-1 infection. Higher HLA-C levels may lead to better control of HIV-1 infection through both a higher efficiency of antigen...
8.
Serena M, Parolini F, Biswas P, Sironi F, Miranda A, Zoratti E, et al.
Sci Rep
. 2017 Jan;
7:40037.
PMID: 28051183
HLA-C has been demonstrated to associate with HIV-1 envelope glycoprotein (Env). Virions lacking HLA-C have reduced infectivity and increased susceptibility to neutralizing antibodies. Like all others MHC-I molecules, HLA-C requires...
9.
Sironi F, Malnati M, Mongelli N, Cozzi P, Guzzo C, Ghezzi S, et al.
J Transl Med
. 2015 Apr;
13:107.
PMID: 25888743
Background: Combined antiretroviral therapy has drastically reduced mortality and morbidity of HIV-infected individuals. Nevertheless long-term toxicity and appearance of viral resistance hampers the prolonged effectiveness of combination therapy, requiring a...
10.
Varchetta S, Lusso P, Hudspeth K, Mikulak J, Mele D, Paolucci S, et al.
Retrovirology
. 2013 Dec;
10:154.
PMID: 24330394
Background: Sialic acid-binding Ig-like lectin-7 (Siglec-7) expression is strongly reduced on natural killer (NK) cells from HIV-1 infected viremic patients. To investigate the mechanism(s) underlying this phenomenon, we hypothesized that...